BRIEF published on 04/07/2026 at 19:35, 6 months 23 days ago GENFIT Releases 2025 Universal Registration Document Liver Diseases GENFIT R&D Portfolio 2025 Registration Document Iqirvo® Approval
BRIEF published on 04/07/2026 at 19:35, 6 months 23 days ago GENFIT publie le document d'enregistrement universel 2025 GENFIT Maladies Du Foie Document D'immatriculation 2025 Approbation Iqirvo® Portefeuille De R&D
BRIEF published on 04/07/2026 at 19:35, 6 months 23 days ago GENFIT makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document Liver Diseases GENFIT
BRIEF published on 04/07/2026 at 19:35, 6 months 23 days ago Mise à disposition du Document d’Enregistrement Universel 2025 par GENFIT AMF Biopharmaceutique GENFIT Document D’enregistrement Maladies Du Foie
PRESS RELEASE published on 04/07/2026 at 19:30, 6 months 23 days ago GENFIT Announces Publication of the 2025 Universal Registration Document GENFIT announces the publication of the 2025 Universal Registration Document, providing key financial and corporate governance information. Available for public viewing and download on GENFIT and AMF websites Biopharmaceutical Company Financial Report Liver Diseases GENFIT 2025 Universal Registration Document
PRESS RELEASE published on 04/07/2026 at 19:30, 6 months 23 days ago GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025 GENFIT annonce la disponibilité de son Document d’Enregistrement Universel 2025 auprès de l’AMF. Détails financiers et gouvernance inclus. La société vise l'amélioration des maladies rares du foie AMF Maladies Rares GENFIT Foie Document D’Enregistrement Universel 2025
BRIEF published on 02/12/2026 at 18:40, 8 months 16 days ago GENFIT Secures US$20M Milestone with Iqirvo® Success Clinical Trials Biopharmaceutical GENFIT Milestone Payment Iqirvo
BRIEF published on 02/12/2026 at 18:40, 8 months 16 days ago GENFIT franchit le cap des 20 millions de dollars grâce au succès d'Iqirvo® Biopharmaceutique Essais Cliniques GENFIT Paiement D'étape Iqirvo
BRIEF published on 02/12/2026 at 18:40, 8 months 16 days ago GENFIT accueille un paiement d'étape de 20 M$ grâce aux performances d'Iqirvo® Biopharmaceutique GENFIT Paiement D'étape Ipsen Iqirvo®
BRIEF published on 02/12/2026 at 18:40, 8 months 16 days ago GENFIT welcomes a $20M milestone payment thanks to Iqirvo® performance Biopharmaceutical GENFIT Ipsen Iqirvo® Stage Payment
Published on 10/30/2026 at 23:35, 1 day 15 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 15 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 20 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 23 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 4 hours 53 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 10 hours 28 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 22 hours 53 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 16 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 16 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 16 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
